Menu
Menu
Company Details
Fund type
VC (corporate holding structure)
Team size
6
HQ location
Luxembourg & Hong Kong
Other offices
Beijing
VC advisor team
Various experienced MedTech and Mobility executives with decades of experience across Europe, the US and Asia
VC classification
Cross-border VC (Europe and Asia)
INVESTMENT SCOPE
Investment stages
Seed, Series A
Average ticket size
EUR 2-4 million, with flexibility
Startup geography
Europe, Israel and Asia
EU impact classification
Article 8 - Promoting ESG
Verticals and technologies
Medtech and Mobility
Ascend Capital Partners
Investing in early-stage Medtech and Mobility companies in Europe and Asia
- Seed, Series A
- Hong Kong
About
VC investing in early-stage Medtech and Mobility companies in Europe and Asia, providing hands-on support to expand into Asian, Europa and US.
Portfolio
Portfolio size
7
Annual investments
2-4
Exits
Grundium (PE buy-out, May-22), Aiforia (IPO, Dec-21), IEE (Trade sale, Jan-13), NVC Lighting (HK IPO), TCT Medical (Trade sale), Acorn International (Nasdaq IPO), Bioregen (PE buy-out), China Autoparts (PE buy-out)
Active Funds
Fund
1
- Launch year:
2017
- Size (AUM):
EUR 34 million
- Investor involvement:
Majority partner-funded, with outside participation from HNWs and family offices
- Fund management location:
Luxembourg and Hong Kong
Nordic Connection & Vision
Our vision is for early-stage tech entrepreneurs to realise their full potential by supporting them to capture significant market opportunities in Asia, a geography which they may admire but not have much knowledge, experience or connections to address and, crucially, unlock hidden value in their businesses. We provide close support for our portfolio companies through our active investment approach, bringing financial and industry expertise to bear, as well as connections which blossom into commercial opportunities that accelerate growth. We closely guide entrepreneurs into the market, looking to deepen our strategic support by offering localisation opportunities in Asia, such as setting up local joint ventures and operations. We are a financial investor with a strategic mindset.
Our current portfolio is spread across Europe and Asia, with a strong track record of implementing our successful thesis through them.
All of our partners have substantial experience working in and/or cultural links with Asia, as well as Europe.
INVESTOR COLLABORATION
- Lead investments:
Yes (e.g. Canatu, TactoTek, Grundium, Aiforia)
- Syndicate investments:
Yes
- Follow investments:
Yes
UPCOMING FUND
Fund size
EUR 60-80 million
Fund thesis
Investing in European high-tech early-stage medtech and mobility tech firms, supporting them to grow in Asia/US, as well as Asian companies and growth in Europe/US
Closing date
Q4 2022